Biotech Startup, Immusoft, Wants To Turn Body's Cells Into Drug Factories

Matthew Scholz's past entrepreneurial projects have included software for mobile apps and GPS-based logistics. That may make it easier to understand why his latest business venture in biotechnology would still involve some programming basics. "It struck me that the way the body attacks a pathogen is similar to the way a computer attacks a password," Scholz said. "You have this idea of immunity memory. If you get a vaccine, your body remembers it and suddenly the disease that used to kill you won't even give you the sniffles. And I thought, well, if it remembers that, where does it store the information, and why can't we change it? So we really set about treating disease from an information-based perspective."

Hey, check out all the research scientist jobs. Post your resume today!